Argenx
ARGX
#440
Rank
โ‚น4.759 T
Marketcap
โ‚น76,427
Share price
-1.74%
Change (1 day)
43.77%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚น4.759 Trillion

As of December 2025 Argenx has a market cap of โ‚น4.759 Trillion. This makes Argenx the world's 440th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น4.759 T48.14%
2024โ‚น3.212 T71.02%
2023โ‚น1.878 T8.32%
2022โ‚น1.734 T26.7%
2021โ‚น1.368 T33.48%
2020โ‚น1.025 T109.06%
2019โ‚น490.51 B100.08%
2018โ‚น245.15 B91.51%
2017โ‚น128.01 B
2014โ‚น9.22 B

End of Day market cap according to different sources

On Dec 18th, 2025 the market cap of Argenx was reported to be:

โ‚น4.661 Trillion
by Nasdaq info icon info icon
โ‚น4.759 Trillion
by CompaniesMarketCap info icon info icon